Lars Rebien Sorensen
Chair of BoardMr. Lars Rebien Sorensen is Executive Vice Chairman of the Board of Ferring Holding SA from June 2023. He was Executive Chairman of the Board of Ferring Holding SA from July 2021 to July 01, 2023. He is Vice Chairman of the Board of Ferring Pharmaceuticals Ltd. from June 2023. He was Chairman of the Board of Ferring Pharmaceuticals Ltd. from July 2021 to June 2023. He is Chairman of the Board of Ferring B.V. from July 2021. He is Chair of Board of Novo Nordisk A/S from November 14, 2025. He joined the Novo Nordisk A/S in November 2000. He was Observer of Novo Nordisk A/S from May 2025 to November 14, 2025. He was Chief Executive Officer and President of Novo Nordisk A/S. He is Director of Jungbunzlauer Suisse AG. He was Member of the Board of Novo Holdings A/S from 2017. He was Chairman of Novo Holdings A/S from June 2018. He was Director of Novo Holdings A/S. He was Member of the Supervisory Board of Bertelsmann SE & Co. KGaA. He was employed at Bertelsmann SE & Co. KGaA from May 18, 2005 to May 05, 2015. He was Chief Executive Officer of Novo Nordisk A/S and President of Novo Nordisk A/S of Novo Nordisk Inc. until 2016. He was employed at Novo Nordisk Inc. until 2016. He was Independent Director of Thermo Fisher Scientific Inc. from May 18, 2016. He joined the Thermo Fisher Scientific Inc. on May 18, 2016. He was Director of ZymoGenetics, Inc. He was employed at ZymoGenetics, Inc. from January 1996 to March 2010. He was Equity Analyst of Handelsbanken Capital Markets AB, Research Division. He was Chief Executive Officer, President and Director of Danmarks Nationalbank. He was Director of Ørsted A/S. He was employed at Ørsted A/S from 2007 to April 18, 2012. He was Director of Svenska Cellulosa Aktiebolaget SCA (publ) until June 15, 2017. He was employed at Svenska Cellulosa Aktiebolaget SCA (publ) from April 05, 2017 to June 15, 2017. He was Chairman of Advisory Board of Axcel Management A/S. He was Deputy Chairman of Supervisory Board of Carlsberg A/S from 2015 to March 13, 2019. He was employed at Carlsberg A/S from March 2015 to March 13, 2019. He was Chairman of Supervisory Board of Carlsberg Breweries A/S from April 17, 2015 to March 14, 2019. He was employed at Carlsberg Breweries A/S from April 17, 2015 to March 14, 2019. He was Director of SAS AB. He was employed at SAS AB from 2001 to April 2006. He was Director of Ørsted Bioenergy & Thermal Power A/S. He joined the Ørsted Bioenergy & Thermal Power A/S in 2007. He was Independent Director of Essity AB (publ) from 2017 to March 29, 2023. He was employed at Essity AB (publ) from 2017 to March 29, 2023. He was Chief Executive Officer of Novo Nordisk and President of Novo Nordisk of Novo Nordisk Canada Inc. until 2016. He was employed at Novo Nordisk Canada Inc. until 2016. He has B.S. in International Economics from Copenhagen Business School Handelshøjskolen in 1983, Bachelor's in International Economics from Copenhagen Business School Handelshøjskolen, M.S. in Forestry from Københavns Universitet, M.S. in Forestry from Det Natur- og Biovidenskabelige Fakultet in 1981.
Positions
- Company NameNovo Nordisk A/SStock CodeNVOPositionChair of BoardColleagues
- KMKarsten Munk KnudsenExecutive VP, CFO & Member of the Management Board
- MMMaziar Mike DoustdarPresident, CEO & Member of the Management Board
- MHMartin Holst LangeEVP of R&D, Chief Scientific Officer and Member of the Management Board
- TSTania SabroeEVP of People, Organisation and Corporate Affairs & Member of Management Board
- THThilde Hummel BogebjergExecutive VP of Enterprise IT & Quality and Member of Management Board
- CDCornelis de JongIndependent Vice Chair of the Board
- SEStephan EngelsIndependent Director
- DJDesirée Jantzen AsgreenEmployee Representative Director
- MBMette Bojer JensenEmployee Non-Independent Representative Director
